Copyright: ©Author(s) 2026.
World J Gastroenterol. Apr 14, 2026; 32(14): 117396
Published online Apr 14, 2026. doi: 10.3748/wjg.v32.i14.117396
Published online Apr 14, 2026. doi: 10.3748/wjg.v32.i14.117396
Table 1 Roles of different innate immune cells in the progression of metabolic dysfunction-associated steatotic liver disease
| Cells | Markers | Functions | Ref. |
| cDCs | CD103 | Adoptive transfer of CD103-expressing cDCs protected liver inflammation and damage in Batf3-deficient animals with a high sucrose diet or MCD diet during MASH progression | Heier et al[15] |
| cDCs | XCR1+ | XCR1+ cDC1 cells influence inflammatory T cell reprogramming and exacerbate MASH development | Deczkowska et al[16] |
| Macrophages | MERTK | Ablation of MERTK signaling by disintegrin and metalloproteinase domain-containing protein 17 decreased MASH progression | Cai et al[23] |
| Macrophages | Ly6C+OPN+ | Infiltration of Ly6C+OPN+ lipid-associated macrophages promoted MASH progression | Kui et al[38] |
| Neutrophils | Ly6G+H3Cit+ | Infiltration of Ly6G+H3Cit+ neutrophils promoted MASH progression | Kui et al[38] |
| NK cells | CXCR3+ | CXCR3+ NK cells decreased liver inflammation in MCD-induced MASH in mice | Fan et al[44] |
| NKT cells | IL-17A+ | IL-17A-expressing invariant NKT cells in peripheral blood mononuclear cells were associated with MASH progression in patients | Maricic et al[51] |
| MAIT cells | TCRVa7.2+ CD161high CD3+ | The frequency of MAIT cells in circulating blood in patients with MASH decreased compared to that in the group with steatosis or healthy controls | Waller et al[52] |
| ILCs | CD45+ TCRβ- B220-; NK1.1+ CD49a+ CD49b- | Increasing the frequency of ILC1 frequency by fecal microbiota transplantation and indole-3-carbinol inhibited MASLD | Hou et al[58] |
- Citation: Yang M, Olaoba OT, Chinwo SC, LeVasseur H, Zhou B, Kimchi ET, Staveley-O’Carroll KF, Li G. Roles of hepatic immunity in metabolic dysfunction-associated steatotic liver disease: Cellular and molecular mechanisms and clinical trials. World J Gastroenterol 2026; 32(14): 117396
- URL: https://www.wjgnet.com/1007-9327/full/v32/i14/117396.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i14.117396